Immunological comparison of the usual and atypical human serum cholinesterase phenotypes
- PMID: 6838493
Immunological comparison of the usual and atypical human serum cholinesterase phenotypes
Abstract
Antiserum prepared against highly purified usual human serum cholinesterase (the most common phenotype) cross-reacted identically with the atypical serum cholinesterase. The level of circulating atypical enzyme protein, determined immunologically, was about 30% lower when the enzyme came from an atypical rather than a usual phenotype, and the level of enzyme activity measured enzymatically at Vmax with either o-nitrophenylbutyrate or benzoylcholine as substrate showed approximately the same degree of reduction. The average specific activity (activity at Vmax per microgram of enzyme protein) in sera from 28 usual and 20 atypical individuals did not differ significantly. These findings suggest that the atypical enzyme not only has altered catalytic properties (Km) but also might be synthesized more slowly, or cleared in vivo more rapidly, than the usual enzyme.
Similar articles
-
Comparison of atypical and usual human serum cholinesterase. Purification, number of active sites, substrate affinity, and turnover number.J Biol Chem. 1978 Jan 25;253(2):361-6. J Biol Chem. 1978. PMID: 618874
-
Kinetics of the inhibition of human serum cholinesterase phenotypes with the dimethylcarbamate of (2-hydroxy-5-phenylbenzyl)-trimethylammonium bromide (Ro 02-0683).Biochem Pharmacol. 1991 Nov 27;42(12):2313-6. doi: 10.1016/0006-2952(91)90235-w. Biochem Pharmacol. 1991. PMID: 1764116
-
E1j, a quantitative variant at cholinesterase locus 1: immunological evidence.J Med Genet. 1976 Feb;13(1):43-5. doi: 10.1136/jmg.13.1.43. J Med Genet. 1976. PMID: 818383 Free PMC article.
-
Catalytic properties and distribution profiles of paraoxonase and cholinesterase phenotypes in human sera.Toxicol Lett. 1995 Dec;82-83:447-52. doi: 10.1016/0378-4274(95)03494-3. Toxicol Lett. 1995. PMID: 8597092 Review.
-
Detection of cholinesterase inhibition. The significance of cholinesterase measurements.Ann Clin Lab Sci. 1988 Sep-Oct;18(5):345-52. Ann Clin Lab Sci. 1988. PMID: 3052242 Review.
Cited by
-
Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.Chem Res Toxicol. 2016 Sep 19;29(9):1381-92. doi: 10.1021/acs.chemrestox.6b00228. Epub 2016 Aug 31. Chem Res Toxicol. 2016. PMID: 27551784 Free PMC article. Review.
-
Protandim does not influence alveolar epithelial permeability or intrapulmonary oxidative stress in human subjects with alcohol use disorders.Am J Physiol Lung Cell Mol Physiol. 2012 Apr 1;302(7):L688-99. doi: 10.1152/ajplung.00171.2011. Epub 2012 Jan 20. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 22268125 Free PMC article. Clinical Trial.
-
DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites.Am J Hum Genet. 1992 May;50(5):1086-103. Am J Hum Genet. 1992. PMID: 1570838 Free PMC article.
-
Cholinesterase variants: rapid characterisation by PCR/SSCP and evidence for molecular homogeneity.J Med Genet. 1995 Feb;32(2):109-12. doi: 10.1136/jmg.32.2.109. J Med Genet. 1995. PMID: 7760318 Free PMC article.
-
Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing.Cell Mol Neurobiol. 1991 Feb;11(1):79-89. doi: 10.1007/BF00712801. Cell Mol Neurobiol. 1991. PMID: 2013061 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources